Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry

Launched by CHINA NATIONAL CENTER FOR CARDIOVASCULAR DISEASES · Oct 26, 2022

Keywords

ClinConnect Summary

This clinical trial is looking into how to better assess the risk of stroke for patients in China who have a heart condition called atrial fibrillation (AF). Atrial fibrillation can lead to blood clots, increasing the risk of stroke. The researchers want to test existing methods for determining stroke risk and create a new assessment tool specifically for Chinese patients with AF. This study is currently recruiting participants aged 18 and older, who have a documented history of atrial fibrillation and can give their consent to join.

If you decide to participate, you'll be part of a nationwide study that aims to improve the way doctors evaluate stroke risk for people with atrial fibrillation. However, certain individuals, such as those with specific heart valve issues or those who have had certain procedures related to AF, will not be eligible to join. Overall, this trial is important as it could lead to better care and prevention strategies for patients at risk of stroke due to atrial fibrillation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years of age or older; male or female.
• • History of documented atrial fibrillation.
• • Able to provide written informed consent.
• Exclusion Criteria:
• • Subjects with moderate or severe mitral stenosis or a mechanical heart valve
• • Subjects with previous or planned AF ablation.
• • Subjects with previous or planned left atrial appendage closure.
• • Subjects unable to cooperate with follow-up after assessment.